Critical immunotherapy target marks dysfunctional regulatory T cells in brain cancer
News Apr 22, 2016
Immunotherapy represents an exciting advance in cancer treatment that harnesses the immune system to seek and destroy cancer cells.
The programmed death 1 (PD-1) pathway dampens immune responses to tumor cells, and several clinical trials have shown favorable outcomes by targeting PD-1 or its ligand PD-1L.
In JCI Insight, David Hafler and colleagues at Yale University and Massachusetts Institute of Technology examined PD-1-expressing regulatory T cells in glioblastoma multiforme, an extremely aggressive form of brain cancer.
Regulatory T cells normally constrain immune responses and keep other types of T cells from mounting hyper-aggressive responses.
Although anti-PD1 therapy is generally thought to promote conventional T cell activity, the Hafler team now reports that PD-1 expression on regulatory T cells from the tumors of glioblastoma multiforme patients correlates with regulatory T cell dysfunction.
They also found that glioblastoma multiforme patients treated with a PD-1 blocking antibody had a higher proportion of dysfunctional regulatory T cells.
These observations suggest the possibility that PD-1 targeting therapies could work, in part, by driving further regulatory T cell dysfunction.
Future studies will be needed to more fully understand the contribution of this pathway to anti-tumor effects.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Lowther DE et al. PD-1 marks dysfunctional regulatory T cells in malignant gliomas. JCI Insight, Published April 21 2016. doi: 10.1172/jci.insight.85935
Algorithm Enables Real-time Brain Scan RegisteringNews
Machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.READ MORE
Gut Microbes May Contribute to Depression and AnxietyNews
Like everyone, people with type 2 diabetes and obesity suffer from depression and anxiety, but even more soREAD MORE
Understanding Brain’s Water System May Prove Beneficial in StrokeNews
If the mechanism can be targeted with medicine, it may prove relevant to all disorders involving increased intracranial pressureREAD MORE
Comments | 0 ADD COMMENT
27th International Conference on Nanomedicine and Nanomaterials
Oct 18 - Oct 19, 2018